EcoDrugPlus

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSPNAG00000010603
Gene Symbol: MLST8
3 Cross references
201 Possible Orthologues:

N-Acetylated-Alpha-Linked Acidic Dipeptidase 2-Like

Ensembl ID : ENSPNAG00000009955
Gene Symbol: LOC108412465
3 Cross references
340 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1-Like

Ensembl ID : ENSPNAG00000007345
Gene Symbol: LOC108414111
3 Cross references
180 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSPNAG00000005957
Gene Symbol: NOX4
2 Cross references
151 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSPNAG00000018789
Gene Symbol: NPC1L1
4 Cross references
189 Possible Orthologues:

Nt-3 Growth Factor Receptor-Like

Ensembl ID : ENSPNAG00000017136
Gene Symbol: LOC108438531
3 Cross references
202 Possible Orthologues:

P-Selectin-Like

Ensembl ID : ENSPNAG00000008133
Gene Symbol: LOC108443223
3 Cross references
45 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSPNAG00000026190
Gene Symbol: LOC108424211
3 Cross references
192 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSPNAG00000010047
Gene Symbol: LOC108424048
3 Cross references
180 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPNAG00000000442
Gene Symbol: PIM3
4 Cross references
172 Possible Orthologues:

Rac-Gamma Serine/threonine-Protein Kinase

Ensembl ID : ENSPNAG00000013934
Gene Symbol: LOC108422057
3 Cross references
203 Possible Orthologues:

Raf Proto-Oncogene Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSPNAG00000022396
Gene Symbol: LOC108427788
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).